"ATIM-16. MRI-GUIDED CONVECTIVE DELIVERY OF MDNA55, AN INTERLEUKIN-4 RECEPTOR TARGETED IMMUNOTHERAPY FOR THE TREATMENT OF RECURRENT GLIOBLASTOMA" by Krystof Bankiewicz

Article

ATIM-16. MRI-GUIDED CONVECTIVE DELIVERY OF MDNA55, AN INTERLEUKIN-4 RECEPTOR TARGETED IMMUNOTHERAPY FOR THE TREATMENT OF RECURRENT GLIOBLASTOMA

Neuro-oncology (2017)

Krystof Bankiewicz, University of California, San Francisco
Achal Achrol, Pacific Neurosciences Institute, Santa Monica, CA, USA
Manish Aghi, University of California, San Francisco
Martin Bexon, Medicenna, Houston, TX, USA
Andrew Brenner, UT Health San Antonio, San Antonio, TX, USA
Nicholas Butowski, University of California, San Francisco
Bradley Elder, Ohio State University
John Floyd, University of Texas at Austin
Russell Lonser, Ohio State University
Fahar Merchant, Medicenna, Houston, TX, USA
Merchant Rosemina, Medicenna, Houston, TX, USA
Toral R Patel, UTSW, Dallas, TX, USA
Dina Randazzo, University of Alabama at Birmingham
Mark Souweidane, Cornell University
Michael Vogelbaum, Department of Neurosurgery, Cleveland, OH, USA
Frank D Vrionis, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA
John Sampson, Duke University

Link

Disciplines

Publication Date

November 6, 2017

DOI

10.1093/neuonc/nox168.111

Citation Information

Krystof Bankiewicz, Achal Achrol, Manish Aghi, Martin Bexon, et al.. "ATIM-16. MRI-GUIDED CONVECTIVE DELIVERY OF MDNA55, AN INTERLEUKIN-4 RECEPTOR TARGETED IMMUNOTHERAPY FOR THE TREATMENT OF RECURRENT GLIOBLASTOMA" Neuro-oncology Vol. 19 (2017)
Available at: http://works.bepress.com/achalsingh-achrol/8/